{"gene":"HFE","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1996,"finding":"HFE (originally called HLA-H) was identified as a novel MHC class I-like gene mutated in hereditary haemochromatosis; the C282Y missense mutation was found homozygous in ~83% of patients, and a second variant H63D was enriched in compound heterozygous patients.","method":"Positional cloning by linkage-disequilibrium and haplotype analysis; sequencing of candidate gene","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 — original positional cloning with mutation identification, replicated immediately across multiple populations","pmids":["8696333"],"is_preprint":false},{"year":1997,"finding":"The C282Y mutation abolishes HFE association with beta2-microglobulin and prevents cell-surface expression, causing retention in the ER/middle Golgi and accelerated degradation; the H63D mutation does not affect beta2-microglobulin binding or surface expression.","method":"Co-immunoprecipitation, immunofluorescence, subcellular fractionation in transfected COS-7 and human embryonic kidney cells","journal":"Proceedings of the National Academy of Sciences / Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (co-IP, immunofluorescence, fractionation) replicated independently by two labs (Waheed et al. PNAS 1997; Feder et al. JBC 1997)","pmids":["9356458","9162021"],"is_preprint":false},{"year":1997,"finding":"HFE protein is associated with beta2-microglobulin and the transferrin receptor (TfR) in human placenta syncytiotrophoblasts at the apical membrane, placing HFE at the site of maternal-fetal iron transfer.","method":"Immunohistochemistry and Western blot co-association from placental membrane fractions","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2-3 — Western blot co-association and IHC localization, single lab","pmids":["9371823"],"is_preprint":false},{"year":1998,"finding":"HFE forms a stable complex with the transferrin receptor (TfR) and lowers TfR affinity for iron-loaded transferrin; the C282Y mutation prevents HFE–TfR association while the H63D mutation allows binding but impairs the affinity reduction.","method":"Co-immunoprecipitation of transfected 293 cells; cell-associated transferrin binding assays; addition of soluble HFE/beta2m to cultured cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal co-IP plus functional transferrin-binding assay, replicated with soluble protein addition","pmids":["9465039"],"is_preprint":false},{"year":1998,"finding":"Crystal structure of HFE at 2.6 Å reveals an MHC-like fold with the hemochromatosis mutation sites mapped; HFE binds TfR tightly at neutral pH but not at acidic endosomal pH, consistent with pH-dependent dissociation in endosomes; TfR:HFE stoichiometry is 2:1, distinct from TfR:transferrin 2:2, yet HFE, transferrin, and TfR form a ternary complex.","method":"X-ray crystallography (2.6 Å); surface plasmon resonance binding at varying pH; biochemical co-complex analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure combined with functional binding measurements","pmids":["9546397"],"is_preprint":false},{"year":1999,"finding":"HFE protein is physically associated with TfR and beta2-microglobulin in crypt enterocytes of the human duodenum; crypt cells show dramatically higher transferrin-bound iron uptake than villus cells, supporting a role for the HFE–TfR complex in sensing body iron status in crypt enterocytes.","method":"Immunocytochemistry; Western blot co-immunoprecipitation from duodenal enterocyte fractions; radiolabeled iron uptake assays in isolated crypt and villus cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — co-IP from primary tissue plus functional iron uptake assay","pmids":["9990067"],"is_preprint":false},{"year":1999,"finding":"HFE overexpression in stably transfected HeLa cells decreases iron uptake from diferric transferrin and activates iron-regulatory proteins (IRPs), leading to downregulation of ferritin and upregulation of TfR, indicating HFE reduces the intracellular labile iron pool.","method":"Stable tetracycline-regulated HFE transfection; radioactive iron uptake assay; IRP gel-shift assay; Western blot","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — stable cell system with multiple functional readouts (iron uptake, IRP activity, ferritin/TfR levels)","pmids":["10572108"],"is_preprint":false},{"year":1999,"finding":"HFE competes with transferrin for binding to TfR by binding at or near the transferrin binding site rather than acting allosterically; the Fe-Tf:TfR:HFE ternary complex contains one Fe-Tf and one HFE bound to the TfR homodimer.","method":"Radioactivity-based and surface plasmon resonance (biosensor) competition assays with soluble proteins","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — quantitative in vitro binding assays with defined stoichiometry, replicated by two orthogonal methods","pmids":["10556042"],"is_preprint":false},{"year":2000,"finding":"Crystal structure of the HFE–TfR extracellular complex at 2.8 Å: two HFE molecules grasp each side of the TfR dimer, with HFE helices (the counterpart of the MHC peptide-binding groove) making extensive contacts with TfR helices in the dimerization domain; TfR alone and in complex differ in domain arrangement, suggesting a communication mechanism between TfR chains.","method":"X-ray crystallography at 2.8 Å of the co-complex of soluble HFE and TfR ectodomains","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure of the binary complex","pmids":["10638746"],"is_preprint":false},{"year":2000,"finding":"Binding of HFE to TfR is required for trafficking of HFE to endosomes and for regulation of intracellular iron homeostasis (ferritin reduction, TfR upregulation); a TfR-binding-impaired HFE mutant accumulates at the basolateral surface but fails to regulate iron; restoring endosomal targeting by an LDLR endosomal-targeting sequence does not rescue iron regulation, indicating TfR binding per se is required.","method":"Stable transfection of polarized duodenal epithelial cells; immunofluorescence localization; ferritin and TfR Western blots; chimeric protein rescue experiments","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — clean cell biology with multiple mutants and rescue experiment isolating TfR-binding requirement","pmids":["11146662"],"is_preprint":false},{"year":2000,"finding":"In HFE-transfected human hepatoma cells, HFE–GFP forms a complex with endogenous TfR and beta2-microglobulin, decreases TfR affinity for transferrin (Kd shift from 1.9 to 4.3 nM), reduces the rate of TfR-dependent iron uptake, and slows transferrin recycling from endosome to cell surface.","method":"Co-immunoprecipitation; 59Fe and 125I-transferrin uptake/release assays; Scatchard analysis; pulse-chase recycling assay in HLF hepatoma cells","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays in a single lab with stable transfectant","pmids":["10771090"],"is_preprint":false},{"year":2001,"finding":"Mutational analysis of TfR reveals that five residues at the HFE binding site (L619, R629, Y643, G647, F650) are also required for transferrin binding, confirming that HFE and transferrin compete for overlapping sites on TfR; solution studies show a 2:2 TfR:HFE complex can form at sub-micromolar concentrations.","method":"Site-directed mutagenesis of TfR; surface plasmon resonance binding assays; equilibrium gel-filtration; analytical ultracentrifugation","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with quantitative biophysical methods to map overlapping binding sites","pmids":["11800564"],"is_preprint":false},{"year":2002,"finding":"Wild-type HFE raises cellular iron by inhibiting iron efflux from macrophages (THP-1 cell line and primary macrophages), independent of its competition with transferrin for TfR binding; the H41D HFE mutant loses the ability to inhibit iron release despite retaining TfR binding.","method":"Iron efflux assays in THP-1 monocyte/macrophage cells and primary macrophages from healthy donors and HH patients; HFE transfection; competitive inhibition with transferrin","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — functional assay in multiple cell types including primary human cells with mutant dissection, replicated in patient-derived cells","pmids":["12429850"],"is_preprint":false},{"year":2002,"finding":"Hfe knockout mice show significantly decreased liver hepcidin mRNA at 4 weeks compared to wild-type, and fail to upregulate hepcidin in response to carbonyl-iron loading (5-fold induction in wild-type vs. none in Hfe-/-), establishing that Hfe is required for appropriate hepcidin induction in response to iron stores.","method":"Quantitative RT-PCR of hepcidin mRNA in liver; dietary iron loading experiments; comparison of wild-type vs. Hfe knockout mice at multiple ages","journal":"Blood cells, molecules & diseases","confidence":"High","confidence_rationale":"Tier 2 — genetic KO mouse with iron-loading challenge, multiple timepoints","pmids":["12547226"],"is_preprint":false},{"year":2004,"finding":"Expression of HFE in HT29 colonic cells increases ferritin levels by inhibiting iron efflux rather than affecting transferrin-mediated iron uptake; this effect is independent of TfR1 interaction (shown with W81A mutant) and is associated with decreased hephaestin mRNA.","method":"Stable HFE transfection; ferritin Western blot; 59Fe efflux and uptake assays; real-time RT-PCR","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — functional iron assays with TfR-binding mutant control in a single lab","pmids":["15044462"],"is_preprint":false},{"year":2006,"finding":"HFE and transferrin receptor 2 (TFR2) interact in cells; this interaction is not abolished by hemochromatosis-associated mutations in either protein; TFR2 competes with TFR1 for HFE binding, suggesting a model in which HFE can signal iron status via either receptor.","method":"Co-immunoprecipitation in transfected cells; competition binding assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP in transfected cells, single lab, no in vivo validation in this paper","pmids":["16893896"],"is_preprint":false},{"year":2008,"finding":"Mouse strains engineered to constitutively favour the Hfe/Tfr1 interaction develop iron overload with inappropriately low hepcidin; strains carrying mutations that prevent the Hfe/Tfr1 interaction develop iron deficiency with inappropriately high hepcidin; liver-specific Hfe overexpression in Hfe-/- mice increases hepcidin and causes iron deficiency — establishing that Hfe induces hepcidin expression when displaced from Tfr1.","method":"Knock-in mouse strains with engineered Tfr1 mutations; liver-specific Hfe transgene; measurement of serum iron, hepcidin mRNA, and iron parameters","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 — multiple complementary genetic mouse models with opposite phenotypes support a coherent mechanistic model","pmids":["18316026"],"is_preprint":false},{"year":2010,"finding":"Hepatocyte-specific delivery of Hfe (via AAV) in Hfe-null mice restores hepcidin mRNA and corrects iron overload; Hfe delivery in Tfr2-deficient mice has no effect, and vice versa, demonstrating that both Hfe and Tfr2 must be present in hepatocytes for normal hepcidin regulation and suggesting Hfe is limiting in the Hfe/Tfr2 hepcidin-regulatory complex.","method":"AAV2/8 hepatocyte-specific gene delivery; hepcidin RT-PCR; serum and liver iron measurements in Hfe-null and Tfr2-deficient mice","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic epistasis with cell-type-specific rescue showing non-redundancy of Hfe and Tfr2","pmids":["20177050"],"is_preprint":false},{"year":2012,"finding":"Hepatocellular overexpression of Hfe in Tfr2-deficient mice still induces hepcidin and causes iron deficiency/microcytic anemia; co-immunoprecipitation of liver lysates found no evidence for Hfe–Tfr2 physical interaction in vivo, suggesting Hfe-dependent hepcidin induction does not require Tfr2.","method":"Hfe transgene expression in Tfr2(Y245X/Y245X) mice; hematological and iron measurements; co-immunoprecipitation from liver lysates","journal":"American journal of hematology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic test with co-IP from liver, but contradicts one prior report; single lab","pmids":["22460705"],"is_preprint":false},{"year":2014,"finding":"HFE overexpression increases Smad1/5/8 phosphorylation and hepcidin expression via the BMP pathway; HFE associates with the BMP type I receptor ALK3, inhibiting ALK3 ubiquitination and proteasomal degradation and increasing ALK3 accumulation at the cell surface; C282Y and H63D HFE mutants both fail to increase ALK3 surface expression; Hfe deletion in mice reduces hepatic ALK3 protein.","method":"Hep3B cell overexpression; Smad phosphorylation immunoblot; co-immunoprecipitation of HFE–ALK3; ubiquitination assay; surface biotinylation; Hfe knockout mouse ALK3 expression","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (co-IP, ubiquitination, surface biotinylation, KO mouse) in a single study","pmids":["24904118"],"is_preprint":false},{"year":2014,"finding":"Wild-type HFE (but not C282Y mutant HFE) inhibits CD8+ T-lymphocyte activation as measured by MIP-1β secretion and 4-1BB expression, independent of MHC I surface levels, beta2-m competition, or TfR interaction; the alpha1-2 domains of HFE mediate this inhibition.","method":"Transient HFE transfection in antigen-presenting cells; co-culture with antigen-specific CD8+ T cells; cytokine ELISA; flow cytometry for 4-1BB; domain deletion mutants","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional cellular assays with domain mapping and mutant controls, single lab","pmids":["24643698"],"is_preprint":false},{"year":2015,"finding":"HJV and HFE regulate hepcidin through distinct mechanisms: Hfe-/-Hjv-/- double-knockout mice phenocopy Hjv-/- for iron overload severity and absence of iron-induced Smad1/5/8 phosphorylation, indicating HFE's ability to induce hepcidin in response to transferrin-bound iron is dependent on HJV-mediated BMP–Smad signalling.","method":"Generation of Hfe-/-, Hjv-/-, and Hfe-/-Hjv-/- double-knockout mice; acute iron challenge; hepcidin mRNA quantification; Smad1/5/8 phosphorylation immunoblot","journal":"Antioxidants & redox signaling","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis using double-KO mice with molecular readouts of BMP–Smad signalling","pmids":["25608116"],"is_preprint":false},{"year":2023,"finding":"Hepatocyte-specific Tfrc (TfR1) knockout mice display inappropriately high hepcidin relative to iron and erythropoietic signals, but ablation of hepatocyte Tfrc has no additional iron phenotype in Hfe knockout mice, demonstrating that the major nonredundant function of hepatocyte TfR1 in iron homeostasis is interaction with HFE to regulate hepcidin; this pathway is modulated by serum iron and contributes to hepcidin suppression in β-thalassemia.","method":"Conditional hepatocyte Tfrc knockout mice (Tfrcfl/fl;Alb-Cre); combined Hfe KO and β-thalassemia mouse models; serum/liver iron, hepcidin, EPO, erythroferrone measurements","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple complementary conditional KO mouse genetic models with comprehensive iron and erythropoietic phenotyping","pmids":["36322932"],"is_preprint":false},{"year":2001,"finding":"An endogenous antisense RNA transcribed from the HFE locus (spanning exon 1, exon 2, and part of intron 1 plus ~1 kb upstream) is polyadenylated with no open reading frame and is ubiquitously expressed; in vitro coupled transcription-translation experiments show this antisense RNA decreases HFE protein expression.","method":"RACE, RT-PCR, dbEST screening, RNase A protection assay, in vitro transcription-translation","journal":"Human molecular genetics","confidence":"Low","confidence_rationale":"Tier 3 — in vitro functional data only; classified as EXCLUDE per alt-locus product (antisense RNA, not the canonical HFE protein); EXCLUDED","pmids":["11532995"],"is_preprint":false}],"current_model":"HFE encodes an MHC class I-like protein that forms a stable complex with beta2-microglobulin and transferrin receptor 1 (TfR1) at the cell surface; in this complex HFE reduces TfR1 affinity for diferric transferrin and is trafficked to endosomes in a TfR1-binding-dependent manner; when displaced from TfR1 by rising diferric transferrin, free HFE in hepatocytes signals via the BMP receptor ALK3 (stabilising it on the cell surface) and HJV-dependent BMP–Smad1/5/8 signalling to upregulate hepcidin, thereby suppressing intestinal iron absorption and macrophage iron release; the pathogenic C282Y mutation prevents beta2-microglobulin binding and cell-surface expression, while H63D retains surface expression but alters TfR1 affinity modulation, both leading to insufficient hepcidin and systemic iron overload."},"narrative":{"teleology":[{"year":1996,"claim":"Positional cloning identified HFE as the gene mutated in hereditary hemochromatosis, establishing the molecular basis for the most common monogenic iron-overload disorder and revealing that C282Y and H63D are the predominant pathogenic alleles.","evidence":"Linkage-disequilibrium mapping and candidate-gene sequencing in hemochromatosis families","pmids":["8696333"],"confidence":"High","gaps":["Protein function unknown at this stage","Mechanism linking mutations to iron overload not established"]},{"year":1997,"claim":"Biochemical characterization showed C282Y abolishes beta2-microglobulin binding and traps HFE in the ER, while H63D retains surface expression, explaining genotype-phenotype differences and establishing that surface expression requires beta2-microglobulin association.","evidence":"Co-immunoprecipitation, immunofluorescence, and subcellular fractionation in transfected cells by two independent labs","pmids":["9356458","9162021"],"confidence":"High","gaps":["Iron-regulatory function of surface HFE unknown","Whether H63D alters iron sensing unresolved"]},{"year":1998,"claim":"Discovery that HFE forms a complex with TfR1 and reduces its affinity for diferric transferrin, together with the 2.6-Å crystal structure revealing an MHC-like fold with pH-dependent TfR binding, provided the first mechanistic link between HFE and iron uptake regulation.","evidence":"Co-IP, transferrin-binding assays, X-ray crystallography, and surface plasmon resonance at varying pH","pmids":["9465039","9546397"],"confidence":"High","gaps":["Whether HFE acts solely through reducing TfR1 affinity or has additional signalling functions","Physiological tissue context not defined"]},{"year":1999,"claim":"Demonstration that HFE competes with transferrin for overlapping sites on TfR1 and that HFE reduces the intracellular labile iron pool via iron-regulatory protein activation unified the structural and functional data into a coherent model of HFE-mediated iron sensing.","evidence":"SPR competition assays, radioactive iron uptake, IRP gel-shift in stable HFE-expressing cells, co-IP from duodenal crypt enterocytes","pmids":["10556042","10572108","9990067"],"confidence":"High","gaps":["Systemic signalling mechanism unknown—hepcidin not yet connected","Relative importance of duodenal versus hepatocyte HFE unclear"]},{"year":2000,"claim":"The 2.8-Å HFE–TfR co-crystal structure revealed the binding interface and showed how HFE grasps the TfR dimer, while cell biology experiments proved that TfR1 binding is required for both endosomal trafficking and iron-regulatory activity of HFE.","evidence":"X-ray crystallography of the HFE–TfR complex; polarized epithelial cell transfection with TfR-binding-impaired and chimeric HFE mutants","pmids":["10638746","11146662"],"confidence":"High","gaps":["How endosomal localisation couples to downstream regulation unclear","In vivo physiological confirmation in mouse models lacking"]},{"year":2002,"claim":"Two key advances established that HFE also inhibits macrophage iron efflux independently of TfR1 competition, and that Hfe is required for hepatic hepcidin induction in response to iron loading, connecting HFE to the master iron-regulatory hormone.","evidence":"Iron efflux assays in macrophages from HH patients and THP-1 cells; hepcidin qRT-PCR in Hfe knockout mice with carbonyl-iron loading","pmids":["12429850","12547226"],"confidence":"High","gaps":["Direct mechanism of HFE-to-hepcidin signal transduction undefined","Whether macrophage and hepatocyte functions are connected unknown"]},{"year":2008,"claim":"Genetic mouse models with engineered Tfr1 mutations showed that HFE induces hepcidin specifically when displaced from TfR1 by rising diferric transferrin, establishing the iron-sensing switch model in which TfR1 sequesters HFE and iron saturation liberates it to activate hepcidin signalling.","evidence":"Knock-in mouse strains with constitutive or abolished Hfe–Tfr1 interaction; liver-specific Hfe transgene in Hfe-null mice","pmids":["18316026"],"confidence":"High","gaps":["Identity of the downstream signalling pathway activated by free HFE unknown","Direct effector interaction not identified"]},{"year":2010,"claim":"Hepatocyte-specific Hfe rescue and epistasis with Tfr2 demonstrated that both Hfe and Tfr2 must be present in hepatocytes for normal hepcidin regulation, though whether they form a physical complex in vivo remained disputed.","evidence":"AAV2/8 hepatocyte-specific gene delivery in Hfe-null and Tfr2-deficient mice; co-IP from liver lysates (2012 follow-up found no interaction)","pmids":["20177050","22460705"],"confidence":"High","gaps":["Nature of HFE–TFR2 cooperation (physical complex vs. parallel pathways) unresolved","Downstream effectors still unidentified"]},{"year":2014,"claim":"The downstream effector was identified: HFE associates with the BMP type I receptor ALK3, inhibits its ubiquitination, and stabilises it at the cell surface to activate Smad1/5/8 phosphorylation and hepcidin transcription; both C282Y and H63D mutations abolish ALK3 stabilisation.","evidence":"Co-IP of HFE–ALK3, ubiquitination assays, surface biotinylation in Hep3B cells, and reduced ALK3 protein in Hfe knockout mouse liver","pmids":["24904118"],"confidence":"High","gaps":["Structural basis of the HFE–ALK3 interaction unknown","Whether HFE directly contacts ALK3 or acts through an adaptor not determined"]},{"year":2015,"claim":"Genetic epistasis with HJV placed HFE upstream of the HJV-dependent BMP–Smad pathway: double-knockout Hfe/Hjv mice phenocopied Hjv-null animals, showing HFE's hepcidin-inducing capacity depends on intact HJV–BMP signalling.","evidence":"Hfe/Hjv single- and double-knockout mice with acute iron challenge; Smad1/5/8 phosphorylation immunoblot; hepcidin mRNA quantification","pmids":["25608116"],"confidence":"High","gaps":["Precise molecular ordering of HFE, ALK3, and HJV in the signalling complex not defined","Whether HFE regulates BMP ligand availability in addition to receptor stability unknown"]},{"year":2023,"claim":"Conditional hepatocyte TfR1 ablation proved that TfR1's major nonredundant hepatocyte function is interaction with HFE to regulate hepcidin, and that this pathway is modulated by serum iron and contributes to hepcidin suppression in β-thalassemia.","evidence":"Hepatocyte-specific Tfrc conditional knockout combined with Hfe KO and β-thalassemia mouse models; comprehensive iron and erythropoietic phenotyping","pmids":["36322932"],"confidence":"High","gaps":["Whether erythroferrone and HFE/TfR1 pathways converge on the same Smad complex not tested","Quantitative contribution of HFE pathway versus ERFE pathway in disease states undefined"]},{"year":null,"claim":"The structural basis of the HFE–ALK3 interaction, the precise mechanism by which HFE inhibits ALK3 ubiquitination, and the molecular architecture of the hepatocyte iron-sensing complex (HFE, TFR2, HJV, ALK3) remain undefined.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of HFE–ALK3 complex available","Ubiquitin ligase targeting ALK3 in HFE absence not identified","Whether HFE, TFR2, HJV, and ALK3 form a single signalling complex or operate in parallel remains unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,6,7,10,16,19]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[9,16,19]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,2,5,9,19]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[4,9]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[16,19,21]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[3,6,10,12,13]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,13,22]}],"complexes":["HFE–beta2-microglobulin–TfR1 complex"],"partners":["B2M","TFRC","TFR2","ACVRL1","HJV"],"other_free_text":[]},"mechanistic_narrative":"HFE is an MHC class I-like cell-surface glycoprotein that serves as a central hepatocyte iron sensor coupling circulating transferrin-iron levels to systemic iron homeostasis through transcriptional regulation of hepcidin. HFE forms a beta2-microglobulin-dependent complex with transferrin receptor 1 (TfR1), competitively reducing TfR1 affinity for diferric transferrin; rising serum iron displaces HFE from TfR1, whereupon free HFE stabilizes the BMP type I receptor ALK3 on the cell surface by inhibiting its ubiquitination, thereby activating HJV-dependent BMP–Smad1/5/8 signalling and hepcidin transcription [PMID:9546397, PMID:18316026, PMID:24904118, PMID:25608116]. The C282Y mutation disrupts beta2-microglobulin association and prevents cell-surface expression, while H63D retains surface expression but impairs TfR1 affinity modulation; both cause inappropriately low hepcidin and the iron-loading disorder hereditary hemochromatosis [PMID:8696333, PMID:9356458, PMID:12547226]. Hepatocyte TfR1's major nonredundant role in iron homeostasis is interaction with HFE—conditional hepatocyte Tfrc deletion phenocopies constitutive HFE activation, and combined Hfe/Tfrc ablation shows no additive effect [PMID:36322932]."},"prefetch_data":{"uniprot":{"accession":"Q30201","full_name":"Hereditary hemochromatosis protein","aliases":["HLA-H"],"length_aa":348,"mass_kda":40.1,"function":"Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q30201/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HFE","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HFE","total_profiled":1310},"omim":[{"mim_id":"620121","title":"IRON OVERLOAD, SUSCEPTIBILITY TO; IO","url":"https://www.omim.org/entry/620121"},{"mim_id":"615517","title":"HEMOCHROMATOSIS, TYPE 5; HFE5","url":"https://www.omim.org/entry/615517"},{"mim_id":"614193","title":"TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2","url":"https://www.omim.org/entry/614193"},{"mim_id":"613609","title":"HOMEOSTATIC IRON REGULATOR; HFE","url":"https://www.omim.org/entry/613609"},{"mim_id":"613284","title":"HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HCHGQ3","url":"https://www.omim.org/entry/613284"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HFE"},"hgnc":{"alias_symbol":["HLA-H","HFE1"],"prev_symbol":[]},"alphafold":{"accession":"Q30201","domains":[{"cath_id":"3.30.500.10","chopping":"25-197","consensus_level":"high","plddt":94.23,"start":25,"end":197},{"cath_id":"2.60.40.10","chopping":"208-295","consensus_level":"high","plddt":92.8601,"start":208,"end":295}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q30201","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q30201-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q30201-F1-predicted_aligned_error_v6.png","plddt_mean":88.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HFE","jax_strain_url":"https://www.jax.org/strain/search?query=HFE"},"sequence":{"accession":"Q30201","fasta_url":"https://rest.uniprot.org/uniprotkb/Q30201.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q30201/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q30201"}},"corpus_meta":[{"pmid":"18199861","id":"PMC_18199861","title":"Iron-overload-related disease in HFE hereditary hemochromatosis.","date":"2008","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18199861","citation_count":539,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20471131","id":"PMC_20471131","title":"EASL clinical practice guidelines for HFE hemochromatosis.","date":"2010","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/20471131","citation_count":346,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9371823","id":"PMC_9371823","title":"Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9371823","citation_count":288,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10638746","id":"PMC_10638746","title":"Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor.","date":"2000","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10638746","citation_count":283,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18316026","id":"PMC_18316026","title":"The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.","date":"2008","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18316026","citation_count":278,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12547226","id":"PMC_12547226","title":"Decreased liver hepcidin expression in the Hfe knockout mouse.","date":"2002","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/12547226","citation_count":218,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9620340","id":"PMC_9620340","title":"Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.","date":"1998","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9620340","citation_count":196,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9990067","id":"PMC_9990067","title":"Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9990067","citation_count":195,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11325323","id":"PMC_11325323","title":"Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.","date":"2001","source":"JAMA","url":"https://pubmed.ncbi.nlm.nih.gov/11325323","citation_count":184,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10556042","id":"PMC_10556042","title":"The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10556042","citation_count":154,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10090890","id":"PMC_10090890","title":"Multicentric origin of hemochromatosis gene (HFE) mutations.","date":"1999","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10090890","citation_count":126,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26456104","id":"PMC_26456104","title":"HFE gene: Structure, function, mutations, and associated iron abnormalities.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/26456104","citation_count":110,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12429850","id":"PMC_12429850","title":"The hemochromatosis protein HFE inhibits iron export from macrophages.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12429850","citation_count":105,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11800564","id":"PMC_11800564","title":"Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites.","date":"2001","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11800564","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15290237","id":"PMC_15290237","title":"The origin and spread of the HFE-C282Y haemochromatosis mutation.","date":"2004","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15290237","citation_count":101,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15546588","id":"PMC_15546588","title":"Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences.","date":"2004","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15546588","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9851896","id":"PMC_9851896","title":"Hemochromatosis in Ireland and HFE.","date":"1998","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/9851896","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24904118","id":"PMC_24904118","title":"HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24904118","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19444013","id":"PMC_19444013","title":"HFE-associated hereditary hemochromatosis.","date":"2009","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19444013","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9382962","id":"PMC_9382962","title":"Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis.","date":"1997","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/9382962","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10572108","id":"PMC_10572108","title":"HFE downregulates iron uptake from transferrin and induces iron-regulatory protein activity in stably transfected cells.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10572108","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12149232","id":"PMC_12149232","title":"Regulation of iron absorption in Hfe mutant mice.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12149232","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20177050","id":"PMC_20177050","title":"Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20177050","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12902032","id":"PMC_12902032","title":"Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism.","date":"2003","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/12902032","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11869934","id":"PMC_11869934","title":"H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers.","date":"2002","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/11869934","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17729390","id":"PMC_17729390","title":"Non-HFE haemochromatosis.","date":"2007","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17729390","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14673107","id":"PMC_14673107","title":"Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14673107","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11399207","id":"PMC_11399207","title":"Contribution of different HFE genotypes to iron overload disease: a pooled analysis.","date":"2000","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11399207","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10401000","id":"PMC_10401000","title":"Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10401000","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10925986","id":"PMC_10925986","title":"Histological evaluation of iron in liver biopsies: relationship to HFE mutations.","date":"2000","source":"The American journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/10925986","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26633544","id":"PMC_26633544","title":"The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data.","date":"2015","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26633544","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16678024","id":"PMC_16678024","title":"The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis.","date":"2006","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16678024","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16315138","id":"PMC_16315138","title":"Non-HFE hemochromatosis.","date":"2005","source":"Seminars in liver disease","url":"https://pubmed.ncbi.nlm.nih.gov/16315138","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11729128","id":"PMC_11729128","title":"Molecular aspects of iron absorption and HFE expression.","date":"2001","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/11729128","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28280078","id":"PMC_28280078","title":"Pathophysiological consequences and benefits of HFE mutations: 20 years of research.","date":"2017","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/28280078","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16565419","id":"PMC_16565419","title":"Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation.","date":"2006","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16565419","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11001626","id":"PMC_11001626","title":"Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity.","date":"2000","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/11001626","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11840200","id":"PMC_11840200","title":"HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls.","date":"2001","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/11840200","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9328324","id":"PMC_9328324","title":"Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families.","date":"1997","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9328324","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16847405","id":"PMC_16847405","title":"Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.","date":"2006","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16847405","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11427444","id":"PMC_11427444","title":"Hereditary hemochromatosis since discovery of the HFE gene.","date":"2001","source":"Clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11427444","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22460705","id":"PMC_22460705","title":"Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2.","date":"2012","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/22460705","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10580641","id":"PMC_10580641","title":"The hereditary hemochromatosis gene (HFE): a MHC class I-like gene that functions in the regulation of iron homeostasis.","date":"1999","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/10580641","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11146662","id":"PMC_11146662","title":"Binding to the transferrin receptor is required for endocytosis of HFE and regulation of iron homeostasis.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11146662","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15044462","id":"PMC_15044462","title":"Expression of the hereditary hemochromatosis protein HFE increases ferritin levels by inhibiting iron export in HT29 cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15044462","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11943417","id":"PMC_11943417","title":"Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y.","date":"2002","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/11943417","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32654761","id":"PMC_32654761","title":"The roles of iron and HFE genotype in neurological diseases.","date":"2020","source":"Molecular aspects of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32654761","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10771090","id":"PMC_10771090","title":"Overexpression of hemochromatosis protein, HFE, alters transferrin recycling process in human hepatoma cells.","date":"2000","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10771090","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16537971","id":"PMC_16537971","title":"Iron Imports. VI. HFE and regulation of intestinal iron absorption.","date":"2006","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16537971","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30798813","id":"PMC_30798813","title":"Hemochromatosis: Hereditary hemochromatosis and HFE gene.","date":"2019","source":"Vitamins and hormones","url":"https://pubmed.ncbi.nlm.nih.gov/30798813","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12622622","id":"PMC_12622622","title":"Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda.","date":"2003","source":"Archives of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/12622622","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22098612","id":"PMC_22098612","title":"Iron metabolism and the role of HFE gene polymorphisms in Wilson disease.","date":"2011","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/22098612","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19058322","id":"PMC_19058322","title":"Function of the hemochromatosis protein HFE: Lessons from animal models.","date":"2008","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/19058322","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20607553","id":"PMC_20607553","title":"Factors influencing disease phenotype and penetrance in HFE haemochromatosis.","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20607553","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24653703","id":"PMC_24653703","title":"Molecular basis of HFE-hemochromatosis.","date":"2014","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24653703","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9858853","id":"PMC_9858853","title":"Polymorphisms in the HFE gene.","date":"1999","source":"Human heredity","url":"https://pubmed.ncbi.nlm.nih.gov/9858853","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36322932","id":"PMC_36322932","title":"Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to hepcidin suppression in β-thalassemia.","date":"2023","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/36322932","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23049448","id":"PMC_23049448","title":"Non-HFE hemochromatosis.","date":"2012","source":"Revista brasileira de hematologia e hemoterapia","url":"https://pubmed.ncbi.nlm.nih.gov/23049448","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31636772","id":"PMC_31636772","title":"Diagnosis and Treatment of Genetic HFE-Hemochromatosis: The Danish Aspect.","date":"2019","source":"Gastroenterology research","url":"https://pubmed.ncbi.nlm.nih.gov/31636772","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16103673","id":"PMC_16103673","title":"Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.","date":"2005","source":"Digestion","url":"https://pubmed.ncbi.nlm.nih.gov/16103673","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21625954","id":"PMC_21625954","title":"HFE, MTHFR, and FGFR4 genes polymorphisms and breast cancer in Brazilian women.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21625954","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10660479","id":"PMC_10660479","title":"Mutation analysis of the HFE gene in Brazilian populations.","date":"1999","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/10660479","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19228389","id":"PMC_19228389","title":"Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1.","date":"2009","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/19228389","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11903354","id":"PMC_11903354","title":"A previously undescribed nonsense mutation of the HFE gene.","date":"2002","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11903354","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11040194","id":"PMC_11040194","title":"Differential HFE allele expression in hemochromatosis heterozygotes.","date":"2000","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/11040194","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24321703","id":"PMC_24321703","title":"Non-HFE hemochromatosis: pathophysiological and diagnostic aspects.","date":"2013","source":"Clinics and research in hepatology and gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/24321703","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12547216","id":"PMC_12547216","title":"Frequency of the HFE gene mutations in five Italian populations.","date":"2002","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/12547216","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22244935","id":"PMC_22244935","title":"Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6.","date":"2012","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22244935","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20712796","id":"PMC_20712796","title":"Hepcidin and Hfe in iron overload in beta-thalassemia.","date":"2010","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20712796","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9410471","id":"PMC_9410471","title":"Impact of HLA-H mutations on iron stores in healthy elderly men and women.","date":"1997","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/9410471","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11836162","id":"PMC_11836162","title":"Prevalence of HFE genotypes, C282Y and H63D, in patients with hematologic disorders.","date":"2002","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/11836162","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12364722","id":"PMC_12364722","title":"Mutations in the hemochromatosis gene (HFE) and stroke.","date":"2002","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/12364722","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12714263","id":"PMC_12714263","title":"Association between the HFE mutations and longevity: a study in Sardinian population.","date":"2003","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/12714263","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23512844","id":"PMC_23512844","title":"Telomere length and elevated iron: the influence of phenotype and HFE genotype.","date":"2013","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/23512844","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21082925","id":"PMC_21082925","title":"Clinical penetrance of C282Y homozygous HFE hemochromatosis.","date":"2008","source":"Expert review of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/21082925","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17729389","id":"PMC_17729389","title":"HFE gene in primary and secondary hepatic iron overload.","date":"2007","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17729389","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10660482","id":"PMC_10660482","title":"Mutations of the HFE gene and the risk of hepatocellular carcinoma.","date":"1999","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/10660482","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17284543","id":"PMC_17284543","title":"The H63D variant in the HFE gene predisposes to arthralgia, chondrocalcinosis and osteoarthritis.","date":"2007","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17284543","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11532995","id":"PMC_11532995","title":"Identification of an endogenous RNA transcribed from the antisense strand of the HFE gene.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11532995","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16216474","id":"PMC_16216474","title":"Frequency of hemochromatosis gene (HFE) mutations in Russian healthy women and patients with estrogen-dependent cancers.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/16216474","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31078115","id":"PMC_31078115","title":"HLAIb worldwide genetic diversity: New HLA-H alleles and haplotype structure description.","date":"2019","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31078115","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18393371","id":"PMC_18393371","title":"The role of Hfe in transferrin-bound iron uptake by hepatocytes.","date":"2008","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/18393371","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25608116","id":"PMC_25608116","title":"HJV and HFE Play Distinct Roles in Regulating Hepcidin.","date":"2015","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25608116","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24643698","id":"PMC_24643698","title":"The WT hemochromatosis protein HFE inhibits CD8⁺ T-lymphocyte activation.","date":"2014","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24643698","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12445172","id":"PMC_12445172","title":"HFE gene mutations and iron metabolism in Wilson's disease.","date":"2002","source":"Liver","url":"https://pubmed.ncbi.nlm.nih.gov/12445172","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28350201","id":"PMC_28350201","title":"A role for sex and a common HFE gene variant in brain iron uptake.","date":"2017","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28350201","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15955425","id":"PMC_15955425","title":"Mutations in the hemochromatosis gene (HFE) and multiple sclerosis.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15955425","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10895137","id":"PMC_10895137","title":"The C282Y mutation of the HFE gene is not found in Chinese haemochromatotic patients: multicentre retrospective study.","date":"2000","source":"Hong Kong medical journal = Xianggang yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/10895137","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22908207","id":"PMC_22908207","title":"Hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: a meta-analysis.","date":"2012","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/22908207","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11051367","id":"PMC_11051367","title":"Prevalence and clinical significance of HFE gene mutations in patients with iron overload.","date":"2000","source":"The American journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/11051367","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11929045","id":"PMC_11929045","title":"Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).","date":"2002","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/11929045","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19711434","id":"PMC_19711434","title":"Hereditary hemochromatosis gene (HFE) variants are associated with birth weight and childhood leukemia risk.","date":"2009","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19711434","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12416729","id":"PMC_12416729","title":"HFE and non-HFE hemochromatosis.","date":"2002","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/12416729","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10488796","id":"PMC_10488796","title":"Update on hereditary hemochromatosis and the HFE gene.","date":"1999","source":"Mayo Clinic proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/10488796","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10878571","id":"PMC_10878571","title":"The structure and function of HFE.","date":"2000","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10878571","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18820912","id":"PMC_18820912","title":"Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?","date":"2008","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/18820912","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25064704","id":"PMC_25064704","title":"Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE).","date":"2014","source":"Hematology/oncology clinics of North America","url":"https://pubmed.ncbi.nlm.nih.gov/25064704","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15464655","id":"PMC_15464655","title":"Iron, the HFE gene, and hepatitis C.","date":"2004","source":"Clinics in liver disease","url":"https://pubmed.ncbi.nlm.nih.gov/15464655","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20027482","id":"PMC_20027482","title":"HFE gene mutations and iron status of Brazilian blood donors.","date":"2009","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/20027482","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10870847","id":"PMC_10870847","title":"Relation between HFE mutations and mild iron-overload expression.","date":"2000","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10870847","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8696333","id":"PMC_8696333","title":"A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.","date":"1996","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8696333","citation_count":3126,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20686565","id":"PMC_20686565","title":"Biological, clinical and population relevance of 95 loci for blood lipids.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20686565","citation_count":2873,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24097068","id":"PMC_24097068","title":"Discovery and refinement of loci associated with lipid levels.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24097068","citation_count":2409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21909115","id":"PMC_21909115","title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21909115","citation_count":1610,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9465039","id":"PMC_9465039","title":"The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9465039","citation_count":662,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9138148","id":"PMC_9138148","title":"Global prevalence of putative haemochromatosis mutations.","date":"1997","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9138148","citation_count":660,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11812557","id":"PMC_11812557","title":"Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.","date":"2002","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11812557","citation_count":653,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15858186","id":"PMC_15858186","title":"Hemochromatosis and iron-overload screening in a racially diverse population.","date":"2005","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15858186","citation_count":587,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9546397","id":"PMC_9546397","title":"Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor.","date":"1998","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9546397","citation_count":510,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20133674","id":"PMC_20133674","title":"Binding and uptake of H-ferritin are mediated by human transferrin receptor-1.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20133674","citation_count":447,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9162021","id":"PMC_9162021","title":"The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9162021","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19820697","id":"PMC_19820697","title":"A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19820697","citation_count":423,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20139978","id":"PMC_20139978","title":"Genome-wide association study of hematological and biochemical traits in a Japanese population.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20139978","citation_count":406,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8896550","id":"PMC_8896550","title":"Haemochromatosis and HLA-H.","date":"1996","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8896550","citation_count":363,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20858683","id":"PMC_20858683","title":"Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.","date":"2010","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/20858683","citation_count":361,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21909110","id":"PMC_21909110","title":"Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.","date":"2011","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21909110","citation_count":348,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14752836","id":"PMC_14752836","title":"Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.","date":"2004","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/14752836","citation_count":342,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11479183","id":"PMC_11479183","title":"HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology.","date":"2001","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/11479183","citation_count":331,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9106528","id":"PMC_9106528","title":"Mutation analysis of the HLA-H gene in Italian hemochromatosis patients.","date":"1997","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9106528","citation_count":330,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10194428","id":"PMC_10194428","title":"HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10194428","citation_count":329,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9356458","id":"PMC_9356458","title":"Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9356458","citation_count":312,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19862010","id":"PMC_19862010","title":"Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19862010","citation_count":294,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9024376","id":"PMC_9024376","title":"Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.","date":"1997","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9024376","citation_count":272,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23222517","id":"PMC_23222517","title":"Seventy-five genetic loci influencing the human red blood cell.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23222517","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16893896","id":"PMC_16893896","title":"Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16893896","citation_count":257,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46145,"output_tokens":5295,"usd":0.10893},"stage2":{"model":"claude-opus-4-6","input_tokens":8828,"output_tokens":3182,"usd":0.185535},"total_usd":0.617368,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":59778,"output_tokens":5839,"usd":0.13346},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9694,"output_tokens":3113,"usd":0.189443}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"HFE protein is physically associated with beta2-microglobulin and transferrin receptor (TfR) in human placenta syncytiotrophoblasts, placing HFE at the site of maternal-fetal iron transport and suggesting a role in regulating TfR-mediated iron uptake.\",\n      \"method\": \"Western blot co-immunoprecipitation, immunohistochemistry of human placental membranes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with beta2-microglobulin and TfR, replicated across placenta and later duodenum\",\n      \"pmids\": [\"9371823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HFE protein in crypt enterocytes of the human duodenum is physically associated with TfR and beta2-microglobulin; crypt cells exhibit dramatically higher transferrin-bound iron uptake than villus cells, suggesting HFE modulates sensing of body iron stores through TfR-mediated uptake in crypt cells.\",\n      \"method\": \"Western blot co-immunoprecipitation, immunocytochemistry, radiolabeled iron uptake assays on isolated crypt vs. villus enterocytes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct co-IP plus functional uptake assay with defined cellular phenotype\",\n      \"pmids\": [\"9990067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Crystal structure of the HFE–TfR complex at 2.8 Å resolution shows two HFE molecules grasping each side of a twofold-symmetric TfR dimer; HFE helices corresponding to the MHC peptide-binding groove make extensive contacts with the TfR dimerization domain, and the HFE–TfR complex suggests overlapping binding sites for HFE and transferrin on TfR.\",\n      \"method\": \"X-ray crystallography (2.8 Å co-crystal structure of extracellular domains of HFE and TfR)\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with functional interpretation, landmark paper\",\n      \"pmids\": [\"10638746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HFE competes with diferric transferrin for binding to TfR by binding at or near the transferrin binding site; the Fe-Tf:TfR:HFE ternary complex consists of one Fe-Tf and one HFE bound to a TfR homodimer, and HFE reduces TfR affinity for Fe-Tf.\",\n      \"method\": \"Radioactivity-based and biosensor-based (surface plasmon resonance) binding assays with soluble recombinant proteins\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro binding assays with two orthogonal methods\",\n      \"pmids\": [\"10556042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mutagenesis of TfR residues at the HFE binding site (L619A, R629A, Y643A, G647A, F650Q) reduced both HFE and transferrin binding affinity, confirming that HFE and transferrin compete for overlapping binding sites on TfR; equilibrium gel-filtration and analytical ultracentrifugation established a 2:2 TfR/HFE complex stoichiometry at submicromolar concentrations.\",\n      \"method\": \"Site-directed mutagenesis of TfR, surface plasmon resonance binding assays, equilibrium gel-filtration, analytical ultracentrifugation\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and multiple biophysical methods\",\n      \"pmids\": [\"11800564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Stable overexpression of HFE in HeLa cells decreases iron uptake from diferric transferrin and activates iron-regulatory proteins (IRPs), leading to decreased ferritin and increased TfR levels, demonstrating that HFE modulates the intracellular labile iron pool.\",\n      \"method\": \"Stably transfected cell line with tetracycline-inducible HFE expression; iron uptake assays, IRP activity assay, Western blot\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean gain-of-function with multiple orthogonal biochemical readouts\",\n      \"pmids\": [\"10572108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Wild-type HFE and TfR co-localize in endosomes and at the basolateral membrane of a polarized duodenal epithelial cell line; the primary hemochromatosis mutant C282Y accumulates in the ER/Golgi. Binding to TfR is required for HFE transport to endosomes and regulation of intracellular iron homeostasis (reduced ferritin, elevated TfR), but not for basolateral surface expression.\",\n      \"method\": \"Live-cell fluorescence microscopy, fractionation, ferritin/TfR Western blotting; HFE mutants with impaired TfR binding; addition of LDLR endosomal-targeting sequence to rescue localization\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct localization experiment with multiple mutants and functional rescue, multiple orthogonal methods\",\n      \"pmids\": [\"11146662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HFE overexpression in human hepatoma (HLF) cells decreases the rate of TfR-dependent iron uptake, reduces TfR affinity for transferrin (Kd shift from 1.9 to 4.3 nM), and slows transferrin recycling from endosomes to the cell surface.\",\n      \"method\": \"59Fe uptake assay, 125I-transferrin internalization and recycling pulse-chase, Scatchard binding analysis, co-immunoprecipitation\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays in a single study\",\n      \"pmids\": [\"10771090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Wild-type HFE inhibits iron efflux (iron export) from the monocyte-macrophage cell line THP-1 and from primary macrophages, raising cellular iron; the HH-associated mutant H41D retains TfR1 binding but loses the ability to inhibit iron release, demonstrating these are separable HFE functions. This inhibition of iron export is not competitively blocked by transferrin.\",\n      \"method\": \"Iron efflux assays in THP-1 cells and primary macrophages from healthy donors and HH patients; comparison of wild-type vs. H41D mutant HFE; competitive inhibition experiments with transferrin\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain/loss-of-function in multiple cell types with mechanistic mutant dissection\",\n      \"pmids\": [\"12429850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hfe knockout mice exhibit significantly decreased liver hepcidin (HAMP) mRNA expression compared to wild-type mice at 4 weeks; iron-loaded Hfe knockout mice fail to upregulate hepcidin in response to carbonyl iron diet, unlike wild-type mice, establishing that Hfe is required for normal hepcidin induction by iron stores.\",\n      \"method\": \"Quantitative RT-PCR of liver hepcidin mRNA; dietary iron loading experiments in Hfe-/- vs. wild-type mice\",\n      \"journal\": \"Blood cells, molecules & diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined molecular phenotype, replicated across age groups and iron-loading conditions\",\n      \"pmids\": [\"12547226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Constitutive Hfe/Tfr1 interaction (via knock-in mutation promoting binding) causes iron overload with inappropriately low hepcidin; disruption of the Hfe/Tfr1 interaction causes iron deficiency with inappropriately high hepcidin. High-level liver-specific Hfe transgene in Hfe-/- mice increases hepcidin and causes iron deficiency. Together, these models show that Hfe induces hepcidin expression when it is not in complex with Tfr1.\",\n      \"method\": \"Knock-in mouse strains with mutations in Tfr1 to promote or prevent Hfe/Tfr1 interaction; liver-specific Hfe transgene in Hfe-/- background; measurement of hepcidin mRNA and iron parameters\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic epistasis models with defined molecular and iron phenotypes; strong mechanistic resolution\",\n      \"pmids\": [\"18316026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hepatocyte-specific AAV-mediated expression of Hfe in Hfe-null mice increases hepcidin mRNA and lowers hepatic iron and transferrin saturation; expression of Hfe in Tfr2-deficient mice has no effect, and Tfr2 expression in Hfe-null mice also has no effect, establishing that both Hfe and Tfr2 must act together in hepatocytes for hepcidin regulation and that Hfe is limiting in the Hfe/Tfr2 complex.\",\n      \"method\": \"AAV2/8-mediated hepatocyte-specific gene delivery in Hfe-/- and Tfr2-deficient mice; hepcidin mRNA and liver/serum iron measurements\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo with hepatocyte-specific rescue, clean molecular readouts\",\n      \"pmids\": [\"20177050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HFE overexpression increases Smad1/5/8 phosphorylation and hepcidin expression in hepatocytes via the BMP pathway; HFE physically associates with the BMP type I receptor ALK3, inhibiting ALK3 ubiquitination and proteasomal degradation, thereby increasing ALK3 cell-surface expression. C282Y and H63D HFE mutants both fail to increase ALK3 cell-surface expression. Deletion of Hfe in mice decreases hepatic ALK3 protein expression.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, ubiquitination assay, flow cytometry for cell-surface ALK3, Smad phosphorylation assay, Hfe knockout mouse liver analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, multiple functional assays, in vivo validation in knockout mice, mutant dissection\",\n      \"pmids\": [\"24904118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In HT29 colonic cells (with duodenal characteristics), HFE expression increases ferritin levels by inhibiting iron efflux rather than by affecting TfR1-mediated iron uptake; this effect is independent of HFE's interaction with TfR1 (shown by a W81A mutant with greatly reduced TfR1 affinity giving similar results). HFE expression decreased hephaestin mRNA levels.\",\n      \"method\": \"Stable transfection of HFE and W81A mutant in HT29 cells; iron uptake and efflux assays; ferritin Western blot; RT-PCR for iron transport genes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional iron flux assays with mechanistic mutant, single lab\",\n      \"pmids\": [\"15044462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"An antisense RNA transcribed from the HFE gene locus (spanning exon 1, exon 2, and part of intron 1) is expressed ubiquitously; in vitro coupled transcription-translation experiments show this antisense RNA decreases HFE expression, indicating it may regulate HFE gene expression.\",\n      \"method\": \"RACE, RT-PCR, dbEST screening, RNase A protection assay, in vitro transcription-translation\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNase protection assay confirms biological existence; in vitro functional assay shows regulatory effect; single lab\",\n      \"pmids\": [\"11532995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"H67D knock-in mice (corresponding to human H63D) develop hepatic iron loading; C294Y/C294Y (human C282Y equivalent) > C294Y/H67D > H67D/H67D for severity of hepatic iron loading, establishing that the H67D (H63D) mutation causes partial loss of Hfe function and contributes to murine hereditary hemochromatosis.\",\n      \"method\": \"Knock-in mouse models; hepatic iron concentration measurement by atomic absorption spectrometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knock-in models with defined dose-response iron phenotype\",\n      \"pmids\": [\"14673107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In Hfe knockout hepatocytes, Tfr1-mediated iron and transferrin uptake are increased by 40–70% compared to iron-loaded wild-type hepatocytes with similar Tfr1 expression levels; the Tfr1-independent (putative Tfr2-mediated) pathway has ~100-fold greater iron uptake capacity and is not regulated by Hfe, demonstrating that Hfe specifically regulates Tfr1-mediated iron uptake in hepatocytes.\",\n      \"method\": \"Radiolabeled 125I-Tf/59Fe uptake assays at low (Tfr1 pathway) and high (Tfr1-independent pathway) transferrin concentrations in isolated hepatocytes from Hfe-/- and wild-type mice; Tfr1 and Tfr2 mRNA/protein quantification\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway-specific radiolabeled uptake assays with genetic KO, single lab\",\n      \"pmids\": [\"18393371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Hepatocellular overexpression of Hfe in Tfr2(Y245X/Y245X) mice induces hepcidin expression causing iron deficiency and microcytic anemia, and co-immunoprecipitation of liver lysates does not show physical interaction between Hfe and Tfr2 in vivo, demonstrating that Tfr2 is not essential for Hfe-mediated hepcidin induction.\",\n      \"method\": \"In vivo transgenic overexpression of Hfe in Tfr2-mutant mice; hepcidin mRNA measurement; iron/hematology phenotyping; co-immunoprecipitation of liver lysates\",\n      \"journal\": \"American journal of hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo plus co-IP; contradicts some earlier models\",\n      \"pmids\": [\"22460705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HFE and HJV regulate hepcidin through overlapping but distinct pathways; Hfe-/-Hjv-/- double knockout mice phenocopy Hjv-/- mice for iron overload severity, and iron-induced Smad1/5/8 phosphorylation and hepcidin induction are absent in both Hjv-/- and Hfe-/-Hjv-/- mice, indicating HFE's transferrin-dependent hepcidin regulation depends on HJV/Smad signaling.\",\n      \"method\": \"Double-knockout mouse models (Hfe-/-, Hjv-/-, Hfe-/-Hjv-/-); acute iron delivery; hepcidin mRNA measurement; Smad1/5/8 phosphorylation Western blot\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double KO and defined signaling readout\",\n      \"pmids\": [\"25608116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Hepatocyte-specific Tfrc knockout mice have inappropriately high hepcidin relative to iron levels, and ablation of hepatocyte Tfrc has no additional iron phenotype in Hfe knockout mice, demonstrating that the major nonredundant function of hepatocyte TfR1 in iron homeostasis is to interact with HFE to regulate hepcidin. This regulatory pathway is modulated by serum iron and contributes to hepcidin suppression in β-thalassemia.\",\n      \"method\": \"Conditional (hepatocyte-specific) Tfrc knockout mice alone or combined with Hfe knockout or β-thalassemia model; hepcidin mRNA; serum/liver iron; erythropoietin; erythroferrone measurements\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with epistasis, multiple iron and erythroid parameters, in vivo\",\n      \"pmids\": [\"36322932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Wild-type HFE (but not C282Y-mutated HFE) expressed on antigen-presenting cells inhibits CD8+ T-lymphocyte activation (MIP-1β secretion and 4-1BB expression) independently of MHC I surface levels, beta2-m competition, or HFE interaction with TfR1; the alpha1-2 domains of HFE are responsible for this inhibitory effect.\",\n      \"method\": \"Transient HFE transfection in APC model; co-culture with antigen-specific CD8+ T lymphocytes; cytokine secretion assay; 4-1BB flow cytometry; domain deletion mutants\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with mutant dissection and multiple T-cell activation readouts; single lab\",\n      \"pmids\": [\"24643698\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HFE is an MHC class I-like protein that forms a complex with beta2-microglobulin and binds transferrin receptor 1 (TfR1) at a site overlapping with the transferrin binding site, competing with diferric transferrin to reduce TfR1-mediated iron uptake; when free from TfR1, hepatocyte HFE acts as a hepatic iron sensor that signals through the BMP/Smad pathway (via stabilization of ALK3 and cooperation with HJV) to induce hepcidin expression, the master hormone that restricts intestinal iron absorption and macrophage iron release via ferroportin degradation, while in macrophages HFE also inhibits iron efflux independently of TfR1 binding.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"HFE (originally called HLA-H) was identified as a novel MHC class I-like gene mutated in hereditary haemochromatosis; the C282Y missense mutation was found homozygous in ~83% of patients, and a second variant H63D was enriched in compound heterozygous patients.\",\n      \"method\": \"Positional cloning by linkage-disequilibrium and haplotype analysis; sequencing of candidate gene\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original positional cloning with mutation identification, replicated immediately across multiple populations\",\n      \"pmids\": [\"8696333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The C282Y mutation abolishes HFE association with beta2-microglobulin and prevents cell-surface expression, causing retention in the ER/middle Golgi and accelerated degradation; the H63D mutation does not affect beta2-microglobulin binding or surface expression.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, subcellular fractionation in transfected COS-7 and human embryonic kidney cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences / Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (co-IP, immunofluorescence, fractionation) replicated independently by two labs (Waheed et al. PNAS 1997; Feder et al. JBC 1997)\",\n      \"pmids\": [\"9356458\", \"9162021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"HFE protein is associated with beta2-microglobulin and the transferrin receptor (TfR) in human placenta syncytiotrophoblasts at the apical membrane, placing HFE at the site of maternal-fetal iron transfer.\",\n      \"method\": \"Immunohistochemistry and Western blot co-association from placental membrane fractions\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Western blot co-association and IHC localization, single lab\",\n      \"pmids\": [\"9371823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"HFE forms a stable complex with the transferrin receptor (TfR) and lowers TfR affinity for iron-loaded transferrin; the C282Y mutation prevents HFE–TfR association while the H63D mutation allows binding but impairs the affinity reduction.\",\n      \"method\": \"Co-immunoprecipitation of transfected 293 cells; cell-associated transferrin binding assays; addition of soluble HFE/beta2m to cultured cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal co-IP plus functional transferrin-binding assay, replicated with soluble protein addition\",\n      \"pmids\": [\"9465039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Crystal structure of HFE at 2.6 Å reveals an MHC-like fold with the hemochromatosis mutation sites mapped; HFE binds TfR tightly at neutral pH but not at acidic endosomal pH, consistent with pH-dependent dissociation in endosomes; TfR:HFE stoichiometry is 2:1, distinct from TfR:transferrin 2:2, yet HFE, transferrin, and TfR form a ternary complex.\",\n      \"method\": \"X-ray crystallography (2.6 Å); surface plasmon resonance binding at varying pH; biochemical co-complex analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure combined with functional binding measurements\",\n      \"pmids\": [\"9546397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HFE protein is physically associated with TfR and beta2-microglobulin in crypt enterocytes of the human duodenum; crypt cells show dramatically higher transferrin-bound iron uptake than villus cells, supporting a role for the HFE–TfR complex in sensing body iron status in crypt enterocytes.\",\n      \"method\": \"Immunocytochemistry; Western blot co-immunoprecipitation from duodenal enterocyte fractions; radiolabeled iron uptake assays in isolated crypt and villus cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP from primary tissue plus functional iron uptake assay\",\n      \"pmids\": [\"9990067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HFE overexpression in stably transfected HeLa cells decreases iron uptake from diferric transferrin and activates iron-regulatory proteins (IRPs), leading to downregulation of ferritin and upregulation of TfR, indicating HFE reduces the intracellular labile iron pool.\",\n      \"method\": \"Stable tetracycline-regulated HFE transfection; radioactive iron uptake assay; IRP gel-shift assay; Western blot\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — stable cell system with multiple functional readouts (iron uptake, IRP activity, ferritin/TfR levels)\",\n      \"pmids\": [\"10572108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HFE competes with transferrin for binding to TfR by binding at or near the transferrin binding site rather than acting allosterically; the Fe-Tf:TfR:HFE ternary complex contains one Fe-Tf and one HFE bound to the TfR homodimer.\",\n      \"method\": \"Radioactivity-based and surface plasmon resonance (biosensor) competition assays with soluble proteins\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro binding assays with defined stoichiometry, replicated by two orthogonal methods\",\n      \"pmids\": [\"10556042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Crystal structure of the HFE–TfR extracellular complex at 2.8 Å: two HFE molecules grasp each side of the TfR dimer, with HFE helices (the counterpart of the MHC peptide-binding groove) making extensive contacts with TfR helices in the dimerization domain; TfR alone and in complex differ in domain arrangement, suggesting a communication mechanism between TfR chains.\",\n      \"method\": \"X-ray crystallography at 2.8 Å of the co-complex of soluble HFE and TfR ectodomains\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure of the binary complex\",\n      \"pmids\": [\"10638746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Binding of HFE to TfR is required for trafficking of HFE to endosomes and for regulation of intracellular iron homeostasis (ferritin reduction, TfR upregulation); a TfR-binding-impaired HFE mutant accumulates at the basolateral surface but fails to regulate iron; restoring endosomal targeting by an LDLR endosomal-targeting sequence does not rescue iron regulation, indicating TfR binding per se is required.\",\n      \"method\": \"Stable transfection of polarized duodenal epithelial cells; immunofluorescence localization; ferritin and TfR Western blots; chimeric protein rescue experiments\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean cell biology with multiple mutants and rescue experiment isolating TfR-binding requirement\",\n      \"pmids\": [\"11146662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In HFE-transfected human hepatoma cells, HFE–GFP forms a complex with endogenous TfR and beta2-microglobulin, decreases TfR affinity for transferrin (Kd shift from 1.9 to 4.3 nM), reduces the rate of TfR-dependent iron uptake, and slows transferrin recycling from endosome to cell surface.\",\n      \"method\": \"Co-immunoprecipitation; 59Fe and 125I-transferrin uptake/release assays; Scatchard analysis; pulse-chase recycling assay in HLF hepatoma cells\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays in a single lab with stable transfectant\",\n      \"pmids\": [\"10771090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mutational analysis of TfR reveals that five residues at the HFE binding site (L619, R629, Y643, G647, F650) are also required for transferrin binding, confirming that HFE and transferrin compete for overlapping sites on TfR; solution studies show a 2:2 TfR:HFE complex can form at sub-micromolar concentrations.\",\n      \"method\": \"Site-directed mutagenesis of TfR; surface plasmon resonance binding assays; equilibrium gel-filtration; analytical ultracentrifugation\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with quantitative biophysical methods to map overlapping binding sites\",\n      \"pmids\": [\"11800564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Wild-type HFE raises cellular iron by inhibiting iron efflux from macrophages (THP-1 cell line and primary macrophages), independent of its competition with transferrin for TfR binding; the H41D HFE mutant loses the ability to inhibit iron release despite retaining TfR binding.\",\n      \"method\": \"Iron efflux assays in THP-1 monocyte/macrophage cells and primary macrophages from healthy donors and HH patients; HFE transfection; competitive inhibition with transferrin\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional assay in multiple cell types including primary human cells with mutant dissection, replicated in patient-derived cells\",\n      \"pmids\": [\"12429850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hfe knockout mice show significantly decreased liver hepcidin mRNA at 4 weeks compared to wild-type, and fail to upregulate hepcidin in response to carbonyl-iron loading (5-fold induction in wild-type vs. none in Hfe-/-), establishing that Hfe is required for appropriate hepcidin induction in response to iron stores.\",\n      \"method\": \"Quantitative RT-PCR of hepcidin mRNA in liver; dietary iron loading experiments; comparison of wild-type vs. Hfe knockout mice at multiple ages\",\n      \"journal\": \"Blood cells, molecules & diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO mouse with iron-loading challenge, multiple timepoints\",\n      \"pmids\": [\"12547226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Expression of HFE in HT29 colonic cells increases ferritin levels by inhibiting iron efflux rather than affecting transferrin-mediated iron uptake; this effect is independent of TfR1 interaction (shown with W81A mutant) and is associated with decreased hephaestin mRNA.\",\n      \"method\": \"Stable HFE transfection; ferritin Western blot; 59Fe efflux and uptake assays; real-time RT-PCR\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional iron assays with TfR-binding mutant control in a single lab\",\n      \"pmids\": [\"15044462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HFE and transferrin receptor 2 (TFR2) interact in cells; this interaction is not abolished by hemochromatosis-associated mutations in either protein; TFR2 competes with TFR1 for HFE binding, suggesting a model in which HFE can signal iron status via either receptor.\",\n      \"method\": \"Co-immunoprecipitation in transfected cells; competition binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP in transfected cells, single lab, no in vivo validation in this paper\",\n      \"pmids\": [\"16893896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Mouse strains engineered to constitutively favour the Hfe/Tfr1 interaction develop iron overload with inappropriately low hepcidin; strains carrying mutations that prevent the Hfe/Tfr1 interaction develop iron deficiency with inappropriately high hepcidin; liver-specific Hfe overexpression in Hfe-/- mice increases hepcidin and causes iron deficiency — establishing that Hfe induces hepcidin expression when displaced from Tfr1.\",\n      \"method\": \"Knock-in mouse strains with engineered Tfr1 mutations; liver-specific Hfe transgene; measurement of serum iron, hepcidin mRNA, and iron parameters\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple complementary genetic mouse models with opposite phenotypes support a coherent mechanistic model\",\n      \"pmids\": [\"18316026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hepatocyte-specific delivery of Hfe (via AAV) in Hfe-null mice restores hepcidin mRNA and corrects iron overload; Hfe delivery in Tfr2-deficient mice has no effect, and vice versa, demonstrating that both Hfe and Tfr2 must be present in hepatocytes for normal hepcidin regulation and suggesting Hfe is limiting in the Hfe/Tfr2 hepcidin-regulatory complex.\",\n      \"method\": \"AAV2/8 hepatocyte-specific gene delivery; hepcidin RT-PCR; serum and liver iron measurements in Hfe-null and Tfr2-deficient mice\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic epistasis with cell-type-specific rescue showing non-redundancy of Hfe and Tfr2\",\n      \"pmids\": [\"20177050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Hepatocellular overexpression of Hfe in Tfr2-deficient mice still induces hepcidin and causes iron deficiency/microcytic anemia; co-immunoprecipitation of liver lysates found no evidence for Hfe–Tfr2 physical interaction in vivo, suggesting Hfe-dependent hepcidin induction does not require Tfr2.\",\n      \"method\": \"Hfe transgene expression in Tfr2(Y245X/Y245X) mice; hematological and iron measurements; co-immunoprecipitation from liver lysates\",\n      \"journal\": \"American journal of hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic test with co-IP from liver, but contradicts one prior report; single lab\",\n      \"pmids\": [\"22460705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HFE overexpression increases Smad1/5/8 phosphorylation and hepcidin expression via the BMP pathway; HFE associates with the BMP type I receptor ALK3, inhibiting ALK3 ubiquitination and proteasomal degradation and increasing ALK3 accumulation at the cell surface; C282Y and H63D HFE mutants both fail to increase ALK3 surface expression; Hfe deletion in mice reduces hepatic ALK3 protein.\",\n      \"method\": \"Hep3B cell overexpression; Smad phosphorylation immunoblot; co-immunoprecipitation of HFE–ALK3; ubiquitination assay; surface biotinylation; Hfe knockout mouse ALK3 expression\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (co-IP, ubiquitination, surface biotinylation, KO mouse) in a single study\",\n      \"pmids\": [\"24904118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Wild-type HFE (but not C282Y mutant HFE) inhibits CD8+ T-lymphocyte activation as measured by MIP-1β secretion and 4-1BB expression, independent of MHC I surface levels, beta2-m competition, or TfR interaction; the alpha1-2 domains of HFE mediate this inhibition.\",\n      \"method\": \"Transient HFE transfection in antigen-presenting cells; co-culture with antigen-specific CD8+ T cells; cytokine ELISA; flow cytometry for 4-1BB; domain deletion mutants\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional cellular assays with domain mapping and mutant controls, single lab\",\n      \"pmids\": [\"24643698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HJV and HFE regulate hepcidin through distinct mechanisms: Hfe-/-Hjv-/- double-knockout mice phenocopy Hjv-/- for iron overload severity and absence of iron-induced Smad1/5/8 phosphorylation, indicating HFE's ability to induce hepcidin in response to transferrin-bound iron is dependent on HJV-mediated BMP–Smad signalling.\",\n      \"method\": \"Generation of Hfe-/-, Hjv-/-, and Hfe-/-Hjv-/- double-knockout mice; acute iron challenge; hepcidin mRNA quantification; Smad1/5/8 phosphorylation immunoblot\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis using double-KO mice with molecular readouts of BMP–Smad signalling\",\n      \"pmids\": [\"25608116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Hepatocyte-specific Tfrc (TfR1) knockout mice display inappropriately high hepcidin relative to iron and erythropoietic signals, but ablation of hepatocyte Tfrc has no additional iron phenotype in Hfe knockout mice, demonstrating that the major nonredundant function of hepatocyte TfR1 in iron homeostasis is interaction with HFE to regulate hepcidin; this pathway is modulated by serum iron and contributes to hepcidin suppression in β-thalassemia.\",\n      \"method\": \"Conditional hepatocyte Tfrc knockout mice (Tfrcfl/fl;Alb-Cre); combined Hfe KO and β-thalassemia mouse models; serum/liver iron, hepcidin, EPO, erythroferrone measurements\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple complementary conditional KO mouse genetic models with comprehensive iron and erythropoietic phenotyping\",\n      \"pmids\": [\"36322932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"An endogenous antisense RNA transcribed from the HFE locus (spanning exon 1, exon 2, and part of intron 1 plus ~1 kb upstream) is polyadenylated with no open reading frame and is ubiquitously expressed; in vitro coupled transcription-translation experiments show this antisense RNA decreases HFE protein expression.\",\n      \"method\": \"RACE, RT-PCR, dbEST screening, RNase A protection assay, in vitro transcription-translation\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — in vitro functional data only; classified as EXCLUDE per alt-locus product (antisense RNA, not the canonical HFE protein); EXCLUDED\",\n      \"pmids\": [\"11532995\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HFE encodes an MHC class I-like protein that forms a stable complex with beta2-microglobulin and transferrin receptor 1 (TfR1) at the cell surface; in this complex HFE reduces TfR1 affinity for diferric transferrin and is trafficked to endosomes in a TfR1-binding-dependent manner; when displaced from TfR1 by rising diferric transferrin, free HFE in hepatocytes signals via the BMP receptor ALK3 (stabilising it on the cell surface) and HJV-dependent BMP–Smad1/5/8 signalling to upregulate hepcidin, thereby suppressing intestinal iron absorption and macrophage iron release; the pathogenic C282Y mutation prevents beta2-microglobulin binding and cell-surface expression, while H63D retains surface expression but alters TfR1 affinity modulation, both leading to insufficient hepcidin and systemic iron overload.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HFE is an MHC class I-like protein that functions as a central hepatic iron sensor governing systemic iron homeostasis through regulation of hepcidin expression. HFE associates with beta-2-microglobulin and binds transferrin receptor 1 (TfR1) at a site overlapping with the transferrin-binding site, competing with diferric transferrin and reducing TfR1-mediated iron uptake [PMID:9371823, PMID:10556042, PMID:10638746]; when released from TfR1 in response to rising transferrin saturation, HFE signals through the BMP/Smad pathway by stabilizing the BMP type I receptor ALK3 against ubiquitin-mediated degradation, cooperating with hemojuvelin (HJV) to induce hepcidin transcription [PMID:24904118, PMID:25608116, PMID:18316026]. Independently of TfR1 binding, HFE inhibits iron efflux from macrophages and intestinal cells, a function genetically separable from its TfR1 interaction [PMID:12429850, PMID:15044462]. Loss-of-function mutations in HFE, notably C282Y and H63D, cause hereditary hemochromatosis characterized by progressive hepatic iron overload due to inappropriately low hepcidin [PMID:14673107, PMID:12547226].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that HFE physically associates with beta-2-microglobulin and TfR at sites of iron transport answered the question of how an MHC-like molecule could participate in iron metabolism.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation from human placental membranes\",\n      \"pmids\": [\"9371823\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Functional consequence of the HFE–TfR interaction on iron uptake was not yet demonstrated\",\n        \"No structural basis for how HFE engages TfR\"\n      ]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that HFE competes with diferric transferrin for TfR binding and that HFE overexpression reduces intracellular iron established a direct mechanism by which HFE limits TfR-mediated iron acquisition.\",\n      \"evidence\": \"SPR and radioligand binding assays with recombinant proteins; inducible HFE overexpression in HeLa cells with iron uptake and IRP activity measurements\",\n      \"pmids\": [\"10556042\", \"10572108\", \"9990067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural details of the HFE–TfR interface unknown\",\n        \"Whether HFE acts through TfR-independent mechanisms was untested\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"The 2.8 Å crystal structure of the HFE–TfR complex revealed that HFE contacts the TfR dimerization domain through its MHC-like α1–α2 helices, explaining the competition with transferrin and providing a structural framework for hemochromatosis mutations.\",\n      \"evidence\": \"X-ray co-crystallography of soluble HFE–TfR ectodomains; mutagenesis validation of contact residues\",\n      \"pmids\": [\"10638746\", \"11800564\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The in vivo signaling consequence of disrupting the HFE–TfR interaction was not yet tested\",\n        \"HFE trafficking to endosomes versus cell surface was only beginning to be characterized\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Showing that HFE co-localizes with TfR in endosomes and that TfR binding is required for endosomal delivery and iron-regulatory function—while the C282Y mutant is retained in the ER—linked protein trafficking to the disease mechanism.\",\n      \"evidence\": \"Fluorescence microscopy and fractionation in polarized epithelial cells with HFE point mutants\",\n      \"pmids\": [\"11146662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How endosomal HFE–TfR interaction translates to systemic iron regulation was unclear\",\n        \"Whether HFE has functions independent of TfR binding was unresolved\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that HFE inhibits iron efflux from macrophages independently of TfR1 binding—and that Hfe knockout mice fail to upregulate hepcidin—revealed two separable HFE functions: local iron-export inhibition and systemic hepcidin regulation.\",\n      \"evidence\": \"Iron efflux assays with H41D mutant in THP-1 and primary macrophages; hepcidin mRNA quantification in Hfe-/- mice under dietary iron loading\",\n      \"pmids\": [\"12429850\", \"12547226\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The molecular target of HFE's iron-export inhibition was not identified\",\n        \"How HFE regulates hepcidin transcription was unknown\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"H67D (H63D) knock-in mice demonstrated a graded loss of Hfe function (C294Y > compound > H67D), confirming that both common hemochromatosis mutations compromise HFE activity in vivo with allele-specific severity.\",\n      \"evidence\": \"Knock-in mouse models with hepatic iron quantification by atomic absorption spectrometry\",\n      \"pmids\": [\"14673107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether H63D and C282Y impair the same or distinct HFE functions was not resolved\",\n        \"Hepcidin levels were not measured in these models\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genetic models forcing or preventing HFE–TfR1 interaction showed that free HFE (not complexed with TfR1) induces hepcidin, establishing a 'competition model' where rising transferrin saturation displaces HFE from TfR1 to activate hepcidin signaling.\",\n      \"evidence\": \"Knock-in Tfr1 mutations promoting/preventing Hfe binding; liver-specific Hfe transgene in Hfe-/- mice\",\n      \"pmids\": [\"18316026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Downstream signaling pathway from free HFE to hepcidin promoter was uncharacterized\",\n        \"Whether TfR2 is an obligate partner for HFE in hepcidin induction was debated\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Hepatocyte-specific rescue experiments showed that both HFE and TfR2 must act together in hepatocytes for normal hepcidin regulation, as expression of either alone in the absence of the other had no effect.\",\n      \"evidence\": \"AAV2/8-mediated hepatocyte-specific gene delivery of Hfe in Hfe-/- and Tfr2-deficient mice\",\n      \"pmids\": [\"20177050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether HFE and TfR2 physically interact or converge on a common signaling node was unclear\",\n        \"The BMP/Smad pathway connection was not yet directly tested\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of ALK3 as a direct HFE-binding partner whose ubiquitination and degradation are prevented by HFE provided the missing link between free HFE and BMP/Smad-mediated hepcidin induction; both C282Y and H63D mutants failed to stabilize ALK3.\",\n      \"evidence\": \"Co-immunoprecipitation, ubiquitination assays, cell-surface ALK3 flow cytometry, Smad1/5/8 phosphorylation, and validation in Hfe-/- mouse liver\",\n      \"pmids\": [\"24904118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the E3 ligase targeting ALK3 that HFE opposes is unknown\",\n        \"Structural basis of HFE–ALK3 interaction is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Double-knockout epistasis established that HFE's transferrin-dependent hepcidin regulation requires intact HJV/BMP/Smad signaling, placing HFE upstream of HJV in the iron-sensing pathway.\",\n      \"evidence\": \"Hfe-/-Hjv-/- double-knockout mice with acute iron challenge; Smad1/5/8 phosphorylation and hepcidin mRNA\",\n      \"pmids\": [\"25608116\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether HFE acts directly on HJV or only through ALK3 stabilization is unresolved\",\n        \"Quantitative contribution of HFE versus HJV to basal hepcidin is not defined\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Hepatocyte-specific TfR1 ablation phenocopied constitutive HFE activation (high hepcidin, iron deficiency), and combining TfR1 and Hfe deletion had no additional effect, demonstrating that the primary non-redundant function of hepatocyte TfR1 is to sequester HFE and that this axis is relevant to hepcidin suppression in β-thalassemia.\",\n      \"evidence\": \"Conditional hepatocyte Tfrc knockout alone and crossed with Hfe-/- or β-thalassemia model; hepcidin, iron parameters, erythroferrone\",\n      \"pmids\": [\"36322932\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How erythroferrone or other erythroid signals interact with HFE–TfR1 competition at the molecular level is unknown\",\n        \"Whether therapeutic targeting of the HFE–TfR1 interface can correct iron disorders is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the identity of the E3 ubiquitin ligase that targets ALK3 and is antagonized by HFE; the molecular target through which HFE inhibits iron efflux independently of TfR1; and whether HFE's immunomodulatory function on CD8+ T cells is physiologically relevant in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No E3 ligase identified for ALK3 degradation antagonized by HFE\",\n        \"Iron-export inhibition target (e.g., ferroportin interaction) not directly shown\",\n        \"HFE inhibition of CD8+ T-cell activation demonstrated only in vitro in a single lab\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 5, 7, 8, 10, 12]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6, 12]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [3, 5, 7, 8, 16]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10, 12, 18, 19]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"complexes\": [\n      \"HFE–beta2-microglobulin–TfR1 complex\"\n    ],\n    \"partners\": [\n      \"TFRC\",\n      \"B2M\",\n      \"TFR2\",\n      \"ACVRL1\",\n      \"HJV\",\n      \"ALK3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"HFE is an MHC class I-like cell-surface glycoprotein that serves as a central hepatocyte iron sensor coupling circulating transferrin-iron levels to systemic iron homeostasis through transcriptional regulation of hepcidin. HFE forms a beta2-microglobulin-dependent complex with transferrin receptor 1 (TfR1), competitively reducing TfR1 affinity for diferric transferrin; rising serum iron displaces HFE from TfR1, whereupon free HFE stabilizes the BMP type I receptor ALK3 on the cell surface by inhibiting its ubiquitination, thereby activating HJV-dependent BMP–Smad1/5/8 signalling and hepcidin transcription [PMID:9546397, PMID:18316026, PMID:24904118, PMID:25608116]. The C282Y mutation disrupts beta2-microglobulin association and prevents cell-surface expression, while H63D retains surface expression but impairs TfR1 affinity modulation; both cause inappropriately low hepcidin and the iron-loading disorder hereditary hemochromatosis [PMID:8696333, PMID:9356458, PMID:12547226]. Hepatocyte TfR1's major nonredundant role in iron homeostasis is interaction with HFE—conditional hepatocyte Tfrc deletion phenocopies constitutive HFE activation, and combined Hfe/Tfrc ablation shows no additive effect [PMID:36322932].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Positional cloning identified HFE as the gene mutated in hereditary hemochromatosis, establishing the molecular basis for the most common monogenic iron-overload disorder and revealing that C282Y and H63D are the predominant pathogenic alleles.\",\n      \"evidence\": \"Linkage-disequilibrium mapping and candidate-gene sequencing in hemochromatosis families\",\n      \"pmids\": [\"8696333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protein function unknown at this stage\", \"Mechanism linking mutations to iron overload not established\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Biochemical characterization showed C282Y abolishes beta2-microglobulin binding and traps HFE in the ER, while H63D retains surface expression, explaining genotype-phenotype differences and establishing that surface expression requires beta2-microglobulin association.\",\n      \"evidence\": \"Co-immunoprecipitation, immunofluorescence, and subcellular fractionation in transfected cells by two independent labs\",\n      \"pmids\": [\"9356458\", \"9162021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Iron-regulatory function of surface HFE unknown\", \"Whether H63D alters iron sensing unresolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Discovery that HFE forms a complex with TfR1 and reduces its affinity for diferric transferrin, together with the 2.6-Å crystal structure revealing an MHC-like fold with pH-dependent TfR binding, provided the first mechanistic link between HFE and iron uptake regulation.\",\n      \"evidence\": \"Co-IP, transferrin-binding assays, X-ray crystallography, and surface plasmon resonance at varying pH\",\n      \"pmids\": [\"9465039\", \"9546397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HFE acts solely through reducing TfR1 affinity or has additional signalling functions\", \"Physiological tissue context not defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstration that HFE competes with transferrin for overlapping sites on TfR1 and that HFE reduces the intracellular labile iron pool via iron-regulatory protein activation unified the structural and functional data into a coherent model of HFE-mediated iron sensing.\",\n      \"evidence\": \"SPR competition assays, radioactive iron uptake, IRP gel-shift in stable HFE-expressing cells, co-IP from duodenal crypt enterocytes\",\n      \"pmids\": [\"10556042\", \"10572108\", \"9990067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Systemic signalling mechanism unknown—hepcidin not yet connected\", \"Relative importance of duodenal versus hepatocyte HFE unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"The 2.8-Å HFE–TfR co-crystal structure revealed the binding interface and showed how HFE grasps the TfR dimer, while cell biology experiments proved that TfR1 binding is required for both endosomal trafficking and iron-regulatory activity of HFE.\",\n      \"evidence\": \"X-ray crystallography of the HFE–TfR complex; polarized epithelial cell transfection with TfR-binding-impaired and chimeric HFE mutants\",\n      \"pmids\": [\"10638746\", \"11146662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How endosomal localisation couples to downstream regulation unclear\", \"In vivo physiological confirmation in mouse models lacking\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Two key advances established that HFE also inhibits macrophage iron efflux independently of TfR1 competition, and that Hfe is required for hepatic hepcidin induction in response to iron loading, connecting HFE to the master iron-regulatory hormone.\",\n      \"evidence\": \"Iron efflux assays in macrophages from HH patients and THP-1 cells; hepcidin qRT-PCR in Hfe knockout mice with carbonyl-iron loading\",\n      \"pmids\": [\"12429850\", \"12547226\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mechanism of HFE-to-hepcidin signal transduction undefined\", \"Whether macrophage and hepatocyte functions are connected unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genetic mouse models with engineered Tfr1 mutations showed that HFE induces hepcidin specifically when displaced from TfR1 by rising diferric transferrin, establishing the iron-sensing switch model in which TfR1 sequesters HFE and iron saturation liberates it to activate hepcidin signalling.\",\n      \"evidence\": \"Knock-in mouse strains with constitutive or abolished Hfe–Tfr1 interaction; liver-specific Hfe transgene in Hfe-null mice\",\n      \"pmids\": [\"18316026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the downstream signalling pathway activated by free HFE unknown\", \"Direct effector interaction not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Hepatocyte-specific Hfe rescue and epistasis with Tfr2 demonstrated that both Hfe and Tfr2 must be present in hepatocytes for normal hepcidin regulation, though whether they form a physical complex in vivo remained disputed.\",\n      \"evidence\": \"AAV2/8 hepatocyte-specific gene delivery in Hfe-null and Tfr2-deficient mice; co-IP from liver lysates (2012 follow-up found no interaction)\",\n      \"pmids\": [\"20177050\", \"22460705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nature of HFE–TFR2 cooperation (physical complex vs. parallel pathways) unresolved\", \"Downstream effectors still unidentified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The downstream effector was identified: HFE associates with the BMP type I receptor ALK3, inhibits its ubiquitination, and stabilises it at the cell surface to activate Smad1/5/8 phosphorylation and hepcidin transcription; both C282Y and H63D mutations abolish ALK3 stabilisation.\",\n      \"evidence\": \"Co-IP of HFE–ALK3, ubiquitination assays, surface biotinylation in Hep3B cells, and reduced ALK3 protein in Hfe knockout mouse liver\",\n      \"pmids\": [\"24904118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the HFE–ALK3 interaction unknown\", \"Whether HFE directly contacts ALK3 or acts through an adaptor not determined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Genetic epistasis with HJV placed HFE upstream of the HJV-dependent BMP–Smad pathway: double-knockout Hfe/Hjv mice phenocopied Hjv-null animals, showing HFE's hepcidin-inducing capacity depends on intact HJV–BMP signalling.\",\n      \"evidence\": \"Hfe/Hjv single- and double-knockout mice with acute iron challenge; Smad1/5/8 phosphorylation immunoblot; hepcidin mRNA quantification\",\n      \"pmids\": [\"25608116\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise molecular ordering of HFE, ALK3, and HJV in the signalling complex not defined\", \"Whether HFE regulates BMP ligand availability in addition to receptor stability unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Conditional hepatocyte TfR1 ablation proved that TfR1's major nonredundant hepatocyte function is interaction with HFE to regulate hepcidin, and that this pathway is modulated by serum iron and contributes to hepcidin suppression in β-thalassemia.\",\n      \"evidence\": \"Hepatocyte-specific Tfrc conditional knockout combined with Hfe KO and β-thalassemia mouse models; comprehensive iron and erythropoietic phenotyping\",\n      \"pmids\": [\"36322932\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether erythroferrone and HFE/TfR1 pathways converge on the same Smad complex not tested\", \"Quantitative contribution of HFE pathway versus ERFE pathway in disease states undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of the HFE–ALK3 interaction, the precise mechanism by which HFE inhibits ALK3 ubiquitination, and the molecular architecture of the hepatocyte iron-sensing complex (HFE, TFR2, HJV, ALK3) remain undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of HFE–ALK3 complex available\", \"Ubiquitin ligase targeting ALK3 in HFE absence not identified\", \"Whether HFE, TFR2, HJV, and ALK3 form a single signalling complex or operate in parallel remains unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 6, 7, 10, 16, 19]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [9, 16, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 2, 5, 9, 19]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [4, 9]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [16, 19, 21]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [3, 6, 10, 12, 13]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 13, 22]}\n    ],\n    \"complexes\": [\n      \"HFE–beta2-microglobulin–TfR1 complex\"\n    ],\n    \"partners\": [\n      \"B2M\",\n      \"TFRC\",\n      \"TFR2\",\n      \"ACVRL1\",\n      \"HJV\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}